Welcome to our dedicated page for Braskem Sa SEC filings (Ticker: BAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating feed-stock sensitivities, environmental liabilities, and minority-ownership details inside Braskem’s sprawling SEC filings can feel like cracking a refinery on your own. The company’s cross-border operations, commodity pricing swings, and leadership in green polyethylene make its 10-K and 10-Q reports some of the most technically dense in the chemicals sector.
Stock Titan’s AI turns those hundreds of pages into clear, actionable insight. Want the latest Braskem insider trading Form 4 transactions? We stream them in real-time and flag unusual buying or selling. Need to grasp a Braskem quarterly earnings report 10-Q filing before the market opens? Our machine-learning summaries highlight segment EBITDA, feed-stock spread movements, and sustainability KPIs in minutes. Even unplanned plant shutdowns filed on an 8-K material event are explained plainly—no industry jargon required.
Every disclosure type is here, updated the instant EDGAR posts it: 10-K annual reports for long-term strategy, 10-Q quarterlies for margin trends, 8-Ks for market-moving events, DEF 14A proxy statements for Braskem executive compensation, and Form 4s for Braskem executive stock transactions. Our platform lets professionals:
- Track Braskem Form 4 insider transactions alongside commodity-cycle shifts
- Compare quarter-over-quarter resin pricing in seconds
- Monitor environmental provision changes without scrolling hundreds of pages
- Export AI-generated highlights for board or client decks
Stop parsing dense petrochemical terminology alone. Stock Titan delivers Braskem SEC filings explained simply, so you can focus on decisions, not documentation.
Braskem S.A. reported a significant related-party transaction with Refinaria de Petróleo Riograndense S.A. (RPR), a company jointly controlled by Braskem, Petrobras and Ultrapar. On November 18, 2025, Braskem’s sales of gasoil to RPR reached R$398 million.
The gasoil is supplied by Braskem for use as feedstock in RPR’s production process, with volumes determined based on opportunity rather than fixed minimum or maximum commitments. Braskem states that prices are referenced to the international Platts Gasoil No. 2 USG Waterborne quotation to ensure fair market terms, and that RPR, its partners and its administrators did not participate in Braskem’s internal decision-making or contract negotiations.
Braskem S.A. reported that its subsidiary Braskem Idesa S.A.P.I. did not make the scheduled interest payment due on November 18, 2025 on its Senior Secured Notes due 2029, which have a total outstanding principal of U.S.$900,000,000. Braskem Idesa is in discussions with an ad-hoc group of bondholders of these notes seeking a sustainable capital structure while preserving its operations. Braskem stated it will keep shareholders and the market informed of any relevant developments.
Braskem S.A. reports Q3 2025 interim results showing weak profitability and rising balance-sheet pressure. Consolidated net revenue reached R$17,299 million in Q3 and R$54,616 million for the nine months, generating gross profit of R$2,108 million year-to-date but only R$436 million in Q3 as petrochemical margins stayed under pressure. After financial results and taxes, the company posted a Q3 2025 net loss of R$174 million, though it still shows a small nine‑month net profit of R$68 million, with R$405 million attributable to the parent company.
Liquidity tightened meaningfully: consolidated cash and cash equivalents fell from R$14,986 million at year‑end 2024 to R$6,663 million, while operating activities used R$3,300 million of cash in the first nine months. Total borrowings and debentures were R$44,720 million plus R$13,507 million of Braskem Idesa borrowings, leaving consolidated shareholders’ equity negative at R$3,173 million. In response to a tough macro and industry downcycle, Braskem and Braskem Idesa hired financial and legal advisors to evaluate capital structure options, fully drew a US$1.0 billion stand‑by facility in October 2025, and recorded R$784 million of impairment and related charges from mothballing chlorine and caustic soda assets in Alagoas.
Braskem S.A. (BAK) filed a Form 6-K/A reporting Extraordinary General Meeting results. Shareholders approved bylaw changes and elected a new board member. Attendance reached 97.91% of common shares and 75.77% of preferred shares.
Governance updates were approved by majority vote: (i) Lucas Cive Barbosa was elected to the Board of Directors to complete the current term ending at the Annual General Meeting addressing the December 31, 2025 financial statements; (ii) Article 2 was amended to align the corporate purpose with current activities; (iii) a new Article 20 was included to detail slate-based election rules for the Board of Directors; (iv) Article 26 was amended to update Board approval thresholds in line with IPCA inflation, authorize the Board to assess annual updates, and transfer responsibility for selecting and replacing independent auditors of subsidiaries to the Executive Board; and (v) the bylaws were consolidated and renumbered accordingly.
Voting maps show broad support across items, including approvals for the Article 26 update and the consolidation of the bylaws.
Braskem S.A. filed a Form 6-K updating its bylaws to refine corporate governance and decision-making rules. The changes include a detailed list of corporate objectives, new procedures for electing the Board of Directors via slates at shareholder meetings, and updated approval thresholds in Article 27 adjusted by IPCA, with the Board authorized to decide annually on maintaining or monetarily adjusting these thresholds.
The update also removes from the Board of Directors the duty to select and replace independent auditors of the Company’s subsidiaries. The bylaws reaffirm a Board composed of 11 members with at least 20% independent directors, and a permanent five-member Compliance and Audit Committee linked to the Board. Preferred shares keep a minimum, non-cumulative 6% dividend on unit value and shareholders retain a mandatory dividend of 25% of net income under the stated priority and allocation rules.
Braskem S.A. filed a Form 6-K furnishing the detailed final voting map from its Extraordinary General Meeting held on November 13, 2025. The disclosure consolidates voting instructions from remote ballots and in-person votes, listing the first five digits of each shareholder’s taxpayer ID (CPF/CNPJ), their vote on each agenda item, and their shareholding position, as presented in Exhibit I.
The agenda covered governance matters: (1) replacement of one effective Board member appointed by Novonor S.A. – Under Judicial Reorganization and NSP Investimentos S.A. – Under Judicial Reorganization to complete the term until the Annual General Meeting addressing the fiscal year ending December 31, 2025; (2) amendment to Article 2 of the Bylaws to align the corporate purpose with current activities; (3) inclusion of provisions detailing rules and procedures for electing the Board of Directors; (4) amendment to Article 26 to update approval thresholds, authorize the Board to decide on maintenance or monetary adjustment of such thresholds, and remove from the Board the responsibility for selecting and replacing independent auditors of subsidiaries; and (5) consolidation and renumbering of the Bylaws.
Braskem S.A. filed a Form 6‑K furnishing the final synthetic voting map from its Extraordinary General Meeting held on November 13, 2025. Shareholders approved all items, including the replacement of one Board member appointed by Novonor S.A. and NSP Investimentos S.A., to serve until the Annual General Meeting that will resolve the 2025 financial statements.
Governance changes to the Bylaws were also approved: an update to article 2 to align the corporate purpose with current activities; the inclusion of detailed rules for electing the Board of Directors; and an amendment to article 26 to update Board approval thresholds, authorize the Board to maintain or adjust those thresholds, and remove from the Board the responsibility to select and replace independent auditors of subsidiaries. A consolidation of the Bylaws reflecting these changes was approved. Approval levels ranged from 78.1%–80.2% of share capital, including 97.9% of the total number of ordinary shares and 52.3%–57.1% of the total number of preference shares.
Braskem S.A. filed a Form 6-K reporting decisions from its Extraordinary General Meeting. Shareholders approved the replacement of a board member, bylaw updates to clarify the corporate purpose, new rules for electing directors via a slate system, inflation-linked approval thresholds for the Board, and consolidation of the bylaws.
Lucas Cive Barbosa was elected to the Board to replace Roberto Faldini, serving until the Annual General Meeting that will consider the financial statements for the year ending December 31, 2025. Attendance reached 97.91% of common shares and 75.77% of preferred shares.
Key thresholds now explicitly listed include: Board approval for investments above
Braskem S.A. furnished a consolidated summary of remote voting instructions for its Extraordinary General Meeting to be held on November 13, 2025. The statement aggregates instructions received via the stock transfer agent, the B3 central depositary, and directly by the company.
Key items and indicated vote counts included: replacement of one Board member appointed by Novonor/NSP Investimentos, with Approve 27,975,249; Reject 15,201,798; Abstain 44,142. An amendment to article 2 (corporate purpose wording) showed Approve 43,157,938; Reject 43,373; Abstain 19,878. Inclusion of Board election rules had Approve 27,770,686; Reject 15,439,516; Abstain 10,987. Updating article 26 (approval thresholds, authorization to adjust thresholds, and removing auditor selection for subsidiaries from the Board) showed Approve 43,007,735; Reject 179,098; Abstain 34,356. Consolidation of the Bylaws due to these amendments indicated Approve 43,147,187; Reject 54,372; Abstain 19,630.
Braskem S.A. filed a Form 6-K addressing media reports about a potential change of control. The company stated it is not responsible for, nor does it conduct, any negotiations by its shareholder Novonor regarding a possible sale of the controlling stake. Braskem said it is not aware of the information reported and sought clarification from its controlling shareholder.
Novonor informed that, as of November 11, 2025, there have been no material or binding developments in discussions involving its indirect stake in Braskem. Novonor added that any material developments will be promptly communicated to Braskem so the company can take usual measures.
FAQ
What is the current stock price of Braskem Sa (BAK)?
What is the market cap of Braskem Sa (BAK)?
